The treatment would shorten the course of the disease and cut the number of intensive care patients by one-third, researchers wrote in a letter to the editor published recently.

Michigan Medicine researchers validated the method across seven labs using a number of different testing conditions, reporting their findings in Radiology.

H. Lee Moffitt Cancer Center and Research Institute scientists used low-dose CT and chest x-ray imaging data from the National Lung Screening Trial to create their model.

T1-mapping is already used at many hospitals and researchers from London believe it can be adapted to evaluate children with neuroblastoma tumors.

A new class of radiopharmaceuticals known as "antagonists" offered clinicians enhanced diagnostic options and proved superior to legacy agents for imaging neuroendocrine tumors.

Demand for molecular imaging is likely to grow in the coming years, but most trainees receive little exposure to the burgeoning opportunity during medical school.

Imaging informatics experts from the University of Pennsylvania and Cincinnati Children's Hospital Medical Center shared their successes—using varying levels of technology to connect and improve the patient experience—during SIIM's virtual meeting.

“[Remote reading] could be a new normal in a specific paradigm shift for all of us and we’re going to have to adapt," Matthew Hayes, a PACS Manager at Radiology Partners, said during SIIM's 2020 virtual meeting.